Lisinopril bradycardia
Pro Research Analysisby 
Searched over 200M research papers for "lisinopril bradycardia"
Lisinopril and Bradycardia: A Comprehensive Review
Introduction to Lisinopril and Bradycardia
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is widely used to manage hypertension and heart failure. However, its association with bradycardia, a condition characterized by an abnormally slow heart rate, has been documented in various studies. This article synthesizes the findings from multiple research papers to provide a clear understanding of the relationship between lisinopril and bradycardia.
Case Reports of Bradycardia with Lisinopril
Severe Bradycardia with Concomitant Tizanidine Use
A notable case involved an 85-year-old man who developed severe bradycardia and hypotension after starting tizanidine while on long-term lisinopril therapy. His heart rate dropped to 37 beats per minute, and his blood pressure fell to 60/32 mm Hg. The discontinuation of tizanidine and supportive care led to the resolution of his symptoms, highlighting the potential for drug interactions to exacerbate bradycardia in patients on lisinopril.
BRASH Syndrome
Another case described a 77-year-old woman who developed BRASH syndrome (Bradycardia, Renal failure, Atrioventricular-Nodal blockers, Shock, and Hyperkalemia) while on lisinopril and metoprolol. Her heart rate was 38 beats per minute, and she presented with hyperkalemia and acute kidney injury. Despite initial treatment with atropine and dopamine, her bradycardia persisted until calcium gluconate was administered, which improved her condition .
Mechanisms of Bradycardia Induced by Lisinopril
Reflex Control of Heart Rate
Research on normotensive males has shown that lisinopril can impair vagally mediated reflexes that control heart rate. Specifically, lisinopril attenuated bradycardia induced by the diving reflex, a parasympathetically mediated response. This suggests that lisinopril may increase parasympathetic activity, which could contribute to the absence of reflex tachycardia despite blood pressure reduction.
Age-Related Effects
Studies in rats have indicated that the cardiovascular effects of lisinopril, including its impact on reflex bradycardia, may diminish with age. In older rats, lisinopril further impaired angiotensin-induced reflex bradycardia, which was already compromised due to aging. This suggests that older patients might be more susceptible to bradycardia when treated with lisinopril .
Clinical Implications and Management
Monitoring and Drug Interactions
Given the potential for severe bradycardia, especially when lisinopril is combined with other medications like tizanidine or metoprolol, careful monitoring is essential. Clinicians should be vigilant about drug interactions and consider alternative therapies or dosage adjustments to mitigate risks .
Treatment Strategies
In cases of bradycardia associated with lisinopril, discontinuation of the drug and supportive measures such as fluid resuscitation and electrolyte management can be effective. The use of calcium gluconate has been shown to rapidly improve bradycardia and associated symptoms in cases of BRASH syndrome .
Conclusion
Lisinopril, while effective for managing hypertension and heart failure, can be associated with bradycardia, particularly in the presence of drug interactions or in older patients. Understanding the mechanisms and clinical presentations of lisinopril-induced bradycardia is crucial for effective management and prevention of adverse outcomes. Clinicians should remain vigilant and consider patient-specific factors when prescribing lisinopril to minimize the risk of bradycardia.
Sources and full results
Most relevant research papers on this topic